MMP-9, MMP-11, and MMP13 are highly prevalent in BC; MMP-9 presents a direct relationship to brain metastases in patients affected by BC [106,107,108] while MMP-11 and MMP13 are promising markers that may be a novel target for the treatment of these patients [109]. This evidence concerns the gene MMP9 and breast cancer.